Drug
B Mad Chemotherapy
B Mad Chemotherapy: highest development phase Phase 1/2, developed by Takeda. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Takeda
Trials
| Drug | Phase | Indication |
|---|---|---|
| B-MAD chemotherapy NCT03246750 | Phase 1/2 | Extranodal NK/T-cell Lymphoma |
Latest
No recent events.
Follow B Mad Chemotherapy on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.